Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

beta 2 Adrenergic Receptor anticorps

ADRB2 Reactivité: Humain FACS, Func, IA Hôte: Souris Monoclonal 6H8 unconjugated
N° du produit ABIN2192080
  • Antigène Voir toutes beta 2 Adrenergic Receptor (ADRB2) Anticorps
    beta 2 Adrenergic Receptor (ADRB2) (Adrenergic, beta-2-, Receptor, Surface (ADRB2))
    Reactivité
    • 149
    • 80
    • 68
    • 8
    • 4
    • 4
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 150
    • 8
    • 2
    • 1
    Souris
    Clonalité
    • 142
    • 17
    • 2
    Monoclonal
    Conjugué
    • 75
    • 13
    • 11
    • 10
    • 7
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp beta 2 Adrenergic Receptor est non-conjugé
    Application
    • 105
    • 68
    • 49
    • 37
    • 27
    • 26
    • 26
    • 18
    • 15
    • 9
    • 9
    • 7
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Functional Studies (Func), Immunoassay (IA)
    Réactivité croisée (Details)
    Cross reactivity: Rat : Yes, Guinea Pig : Yes
    Stérilité
    0.2 μm filtered
    Clone
    6H8
    Isotype
    IgG1
    Top Product
    Discover our top product ADRB2 Anticorps primaire
  • Indications d'application
    For flow cytometry, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies, in vitro dilutions have to be optimized in user's experimental setting. Positive Human epidermoid carcinoma cell A431 line control
    Restrictions
    For Research Use only
  • Buffer
    PBS, containing 0.1 % bovine serum albumin
    Stock
    4 °C
    Stockage commentaire
    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
  • Mijares, Lebesgue, Wallukat, Hoebeke: "From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as antagonists." dans: Molecular pharmacology, Vol. 58, Issue 2, pp. 373-9, (2000) (PubMed).

    Lebesgue, Wallukat, Mijares, Granier, Argibay, Hoebeke: "An agonist-like monoclonal antibody against the human beta2-adrenoceptor." dans: European journal of pharmacology, Vol. 348, Issue 1, pp. 123-33, (1998) (PubMed).

  • Antigène
    beta 2 Adrenergic Receptor (ADRB2) (Adrenergic, beta-2-, Receptor, Surface (ADRB2))
    Autre désignation
    Beta2-Adrenoceptor (ADRB2 Produits)
    Synonymes
    anticorps zgc:162188, anticorps adrb2, anticorps Adrb-2, anticorps Badm, anticorps Gpcr7, anticorps ADRB2R, anticorps ADRBR, anticorps B2AR, anticorps BAR, anticorps BETA2AR, anticorps adrenoceptor beta 2, anticorps adrenoceptor beta 2, surface b, anticorps beta2-adrenergic receptor, anticorps adrenergic receptor, beta 2, anticorps ADRB2, anticorps adrb2b, anticorps LOC100136153, anticorps Adrb2
    Sujet
    The monoclonal antibody 6H8 recognizes human beta2-adrenoceptor. The b -adrenoceptors can be divided into b1, b2, b3 and b4-adrenoceptors defined in terms of agonist potencies, b2-adrenoceptors displayed a higher selectivity for nor-adrenaline than for adrenaline. B2-receptors are mainly postsynaptic and are located on a number of tissues including blood vessels, bronchi, GIT, skeletal muscle, liver and mast cell. Activation results in vasodilatation, bronchodilation, relaxation of the GIT, glycogenolysis in the liver, tremor in skeletal muscle and inhibition of histamine release from mast cells. Transduction is via G-proteins coupled to the intracellular second messenger adenylate cyclase. B- receptors are positively coupled to adenylate cyclase via activation of Gs G-protein, however activation of the b2-adrenoceptors results in stimulation and inhibition of adenylate cyclase. The b2- receptor selective agonists are widely used in the treatment of asthma and other related bronchospastic conditions. They are commonly used in the treatment of angina pectoris, cardiac arrhythmia and for the long-term treatment of patients who survive myocardial infarction. B-receptor antagonists have also been used as anti-hypertensive for a number of years. Beta -blockers have also proven useful in the treatment of conditions such as migraine, anxiety disorders, hyperthyroidism, alcohol withdrawal and when applied topically are useful in the treatment of glaucoma and ocular hypertension. Immunogen Free peptide Beta2-H19C
    Pathways
    cAMP Metabolic Process, Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling, Brown Fat Cell Differentiation
Vous êtes ici:
Support technique